However, patients with HER2+ disease in this study seem dependent upon ER-to achieve breast/axillary downstaging, irrespective of tumour burden, which reciprocates to data published from the Memorial Sloan Kettering Cancer Centre, New York [41]. This evidence concerns the gene ERBB2 and neoplasm.